Sort
21,453 grants matching “tuberculosis”
Improving combination chemotherapy of tuberculosis: a computational approach
$421,829Michael A. Lyons · Colorado State University · R01 · FY2018 · AI
Improving combination chemotherapy of tuberculosis: a computational approach
$421,829Michael A. Lyons · Colorado State University · R01 · FY2019 · AI
Advancing New Drug Regimens for MDR/XDR TB
$421,718Eric L Nuermberger · Johns Hopkins University · R01 · FY2011 · AI
PHARMACOKINETICS AND TOXICITY OF SECONDLINE ANTITUBERCULOSIS DRUGS IN HIV-INFECTE
$421,700Anneke Catharina Hesseling · Stellenbosch University · R01 · FY2011 · HD
Sequencing Core
$421,675James C Sacchettini · Harvard Medical School · U19 · FY2016 · AI
Target Identification
$421,606Michael Niederweis · Florida State University · P01 · FY2009 · AI
MYOCOBACTERIAL CELL WALL AND DRUG DISCOVERY
$421,186Colorado State University-Fort Collins · R01 · FY2000 · AI
Oligonucleotides as Tools for Chemotherapy
$420,967Massachusetts General Hospital · R01 · FY2004 · AI
Bacterial Determinants of Tuberculosis Susceptibiliy
$420,930Sarah M Fortune · Univ Of Massachusetts Med Sch Worcester · P01 · FY2017 · AI
DEVELOPMENT OF LIPID VACCINES FOR TUBERCULOSIS
$420,908Antigenics, Inc. · R44 · FY2000 · AI
UAB AIDS International Training and Research Program
$420,900Sten H Vermund · Vanderbilt University · D43 · FY2008 · TW
A Cambodian Clinical Research Network for HIV & TB
$420,898Sok Thim · Cambodian Health Committee · U01 · FY2010 · AI
Systemic AA Amyloidosis Inhibitors
$420,791Alan D. Snow · Proteotech, Inc. · R44 · FY2008 · AR
Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence
$420,693Michelle H Larsen · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · AI
Non-Canonical Cross-presentation in Dendritic Cells Upon TAP Blockade
$420,670Julie Magarian Blander · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AI
Regulation of Early Cytokine Receptors to TB Infection
$420,654Public Health Research Institute · R01 · FY2005 · AI
Menaquinone Biosynthesis: A Drug Target in Gram-Positive Bacteria
$420,643Dean C Crick · Colorado State University · R01 · FY2016 · AI
Innovative Interdisciplinary Approaches to Sustainable Airborne Infection Control
$420,564Edward A. Nardell · Brigham And Women'S Hospital · D43 · FY2014 · TW
Core D: Clinical Sciences
$420,455Jeffrey M Jacobson · Case Western Reserve University · P30 · FY2022 · AI
NEW MEXICO FIVE-YEAR CYCLE PROPOSAL TO FUND TUBERCULOSIS PREVENTION & CONTROL
$420,449Gayle Kenny · New Mexico State Department Of Health · U52 · FY2011 · PS
Menaquinone Biosynthesis: A Drug Target in Gram-Positive Bacteria
$420,437Dean C Crick · Colorado State University · R01 · FY2019 · AI
Menaquinone Biosynthesis: A Drug Target in Gram-Positive Bacteria
$420,351Dean C Crick · Colorado State University · R01 · FY2018 · AI
Biogenesis of Lipoarabinomannan in Mycobacteria
$420,348Mary Jackson · Colorado State University · R01 · FY2017 · AI
Pathogenesis of Infectious Diseases Training Program
$420,337Roy M Gulick · Weill Medical Coll Of Cornell Univ · T32 · FY2013 · AI
Bacterial Cell Wall Composition and the Influence of Antibiotics
$420,303Lynette S Cegelski · Stanford University · R01 · FY2020 · GM